Side effects include but are not limited to thyroid tumors, multiple endocrine neoplasia type 2, hoarseness, trouble swallowing, shortness of breath, pancreatitis, acid reflux, nausea, and allergic reactions to the medication
After 68 weeks, half of the participants taking Semaglutide GLP-1 had lost 15 percent of their body weight, and nearly a third had lost 20 percent
Reduced cravings
Online weight loss services can make medication feel quick and convenient, but patients may receive limited in-person monitoring or little insight into changes in muscle and body fat
Diabetes Management This is a big one
Breastfeeding The safety of semaglutide during breastfeeding remains uncertain: Injectable Forms (Ozempic, Wegovy): Limited data suggest that semaglutide may be present in breast milk, although its unclear what impact, if any, this might have on a nursing infant